CLASS II Device recall · Reported 11 Jun 2025 · FDA Enforcement Report

Verigene Gram Negative Blood Culture (Bc-gn) Nucleic Acid Test recalled

Luminex is recalling Verigene Gram Negative Blood Culture (Bc-gn) Nucleic Acid Test, distributed nationwide in the US. The recall was initiated on 16 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00840487101599, Lot Number 022525021A, exp. 08/26/2025
Quantity recalled89 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1903-2025
FDA event ID
96701
Recalling firm
Luminex, Northbrook, IL
Classification
Class II
Status
Completed
Recall initiated
16 Apr 2025
FDA classified
3 Jun 2025
Reported
11 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

16 Apr 2025Recall initiated by company
3 Jun 2025Classified by FDA+48 days
11 Jun 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.

Product as listed by the FDA

VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test

Where it was distributed

US Nationwide distribution in the states of AL, CA, MN, TX, AZ, NJ, WA, SC, VA, GA, VT, CT, MD.

Nationwide AlabamaArizonaCaliforniaConnecticutGeorgiaMarylandMinnesotaNew JerseySouth CarolinaTexasVirginiaVermontWashington

Questions about this recall

Why was it recalled?

It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.

Which lots are affected?

UDI/DI 00840487101599, Lot Number 022525021A, exp. 08/26/2025

Where was it sold?

US Nationwide distribution in the states of AL, CA, MN, TX, AZ, NJ, WA, SC, VA, GA, VT, CT, MD.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Luminex

All 39

Other Test Kits & Diagnostics recalls

All 2,656